Determining Genotypic Drug Resistance by Ion Semiconductor Sequencing With the Ion AmpliSeq™ TB Panel in Multidrug-Resistant Mycobacterium tuberculosis Isolates

키워드

참고문헌 (40)

1. Rajagopalan S, "Tuberculosis in older adults", Clin Geriatr Med, 32, pp.479~491 (2016)[DOI]
2. Negin J, "Tuberculosis among older adults--time to take notice", Int J Infect Dis, 32, pp.135~137 (2015)[DOI]
3. Cegielski JP, "Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance", Clin Infect Dis, 62, pp.418~430 (2016)
4. Rodrigues C, "Drug susceptibility testing of Mycobacterium tuberculosis against second-line drugs using the Bactec MGIT 960 System", Int J Tuberc Lung Dis, 12, pp.1449~1455 (2008)
5. Meaza A, "Evaluation of genotype MTBDRplus VER 2.0 line probe assay for the detection of MDR-TB in smear positive and negative sputum samples", BMC Infect Dis, 17, pp.280~ (2017)[DOI]
6. Geleta DA, "Xpert MTB", RIF assay for diagnosis of pulmonary tuberculosis in sputum specimens in remote health care facility, 2015, pp.15, 220~
7. Cirillo DM, "Reaching consensus on drug resistance conferring mutations", Int J Mycobacteriol, 5(S1), pp.S33~ (2016)[DOI]
8. Rothberg JM, "An integrated semiconductor device enabling non-optical genome sequencing", Nature, 475, pp.348~352 (2011)[DOI]
9. Colman RE, "Rapid drug susceptibility testing of drug-resistant Mycobacterium tuberculosis isolates directly from clinical samples by use of amplicon sequencing: a proof-of-concept study", J Clin Microbiol, 54, pp.2058~2067 (2016)[DOI]
10. Daum LT, "Characterization of multi-drug resistant Mycobacterium tuberculosis from immigrants residing in the USA using ion torrent full-gene sequencing", Epidemiol Infect, 142, pp.1328~1333 (2014)[DOI]
11. Daum LT, "Next-generation ion torrent sequencing of drug resistance mutations in Mycobacterium tuberculosis strains", J Clin Microbiol, 50, pp.3831~3837 (2012)[DOI]
12. Cingolani P, "A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3", Fly (Austin), 6, pp.80~92 (2012)[DOI]
13. Sandgren A, "Tuberculosis drug resistance mutation database", PLoS Med, 6, pp.e2~ (2009)
14. Bland JM, "Statistical methods for assessing agreement between two methods of clinical measurement", Lancet, 1, pp.307~310 (1986)
15. Jagielski T, "Mutation profiling for detection of isoniazid resistance in Mycobacterium tuberculosis clinical isolates", J Antimicrob Chemother, 70, pp.3214~3221 (2015)
16. Kambli P, "Correlating rrs and eis promoter mutations in clinical isolates of Mycobacterium tuberculosis with phenotypic susceptibility levels to the second-line injectables", Int J Mycobacteriol, 5, pp.1~6 (2016)[DOI]
17. Ramirez-Busby SM, "Systematic review of mutations in pyrazinamidase associated with pyrazinamide resistance in Mycobacterium tuberculosis clinical isolates", Antimicrob Agents Chemother, 59, pp.5267~5277 (2015)[DOI]
18. Kim SY, "Molecular analysis of isoniazid resistance in Mycobacterium tuberculosis isolates recovered from South Korea", Diagn Microbiol Infect Dis, 47, pp.497~502 (2003)[DOI]
19. Nieto RL, "Virulence of Mycobacterium tuberculosis after acquisition of isoniazid resistance: individual nature of katG mutants and the possible role of AhpC", PLoS One, 11, pp.e0166807~ (2016)[DOI]
20. Telenti A, "Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis", Lancet, 341, pp.647~650 (1993)[DOI]
21. Sajduda A, "Molecular characterization of rifampin- and isoniazid-resistant Mycobacterium tuberculosis strains isolated in Poland", J Clin Microbiol, 42, pp.2425~2431 (2004)[DOI]
22. Alcaide F, "Role of embB in natural and acquired resistance to ethambutol in mycobacteria", Antimicrob Agents Chemother, 41, pp.2270~2273 (1997)
23. Belanger AE, "The embAB genes of Mycobacterium avium encode an arabinosyl transferase involved in cell wall arabinan biosynthesis that is the target for the antimycobacterial drug ethambutol", Proc Natl Acad Sci U S A, 93, pp.11919~11924 (1996)[DOI]
24. Brossier F, "Molecular analysis of the embCAB locus and embR gene involved in ethambutol resistance in clinical isolates of Mycobacterium tuberculosis in France", Antimicrob Agents Chemother, 59, pp.4800~4808 (2015)[DOI]
25. Shi D, "Characteristics of embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates in Henan, China", J Antimicrob Chemother, 66, pp.2240~2247 (2011)[DOI]
26. Zhang Z, "Ethambutol resistance as determined by broth dilution method correlates better than sequencing results with embB mutations in multidrug-resistant Mycobacterium tuberculosis isolates", J Clin Microbiol, 52, pp.638~641 (2014)[DOI]
27. Sengstake S, "Pyrazinamide resistance-conferring mutations in pncA and the transmission of multidrug resistant TB in Georgia", BMC Infect Dis, 17, pp.491~ (2017)[DOI]
28. Mphahlele M, "Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates", J Clin Microbiol, 46, pp.3459~3464 (2008)[DOI]
29. Sreevatsan S, "Characterization of rpsL and rrs mutations in streptomycin-resistant Mycobacterium tuberculosis isolates from diverse geographic localities", Antimicrob Agents Chemother, 40, pp.1024~1026 (1996)
30. Jagielski T, "Screening for streptomycin resistance-conferring mutations in Mycobacterium tuberculosis clinical isolates from Poland", PLoS One, 9, pp.e100078~ (2014)[DOI]
31. Finken M, "Molecular basis of streptomycin resistance in Mycobacterium tuberculosis: alterations of the ribosomal protein S12 gene and point mutations within a functional 16S ribosomal RNA pseudoknot", Mol Microbiol, 9, pp.1239~1246 (1993)[DOI]
32. Nair J, "The rpsL gene and streptomycin resistance in single and multiple drug-resistant strains of Mycobacterium tuberculosis", Mol Microbiol, 10, pp.521~527 (1993)[DOI]
33. Rezaei F, "Screening for streptomycin resistance conferring mutations in Mycobacterium tuberculosis isolates from Iran", J Chemother, 29, pp.14~18 (2017)[DOI]
34. Aubry A, "Mycobacterium tuberculosis DNA gyrase: interaction with quinolones and correlation with antimycobacterial drug activity", Antimicrob Agents Chemother, 48, pp.1281~1288 (2004)[DOI]
35. Maruri F, "A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system", J Antimicrob Chemother, 67, pp.819~831 (2012)[DOI]
36. Cui Z, "Association of mutation patterns in gyrA", B genes and ofloxacin resistance levels in Mycobacterium tuberculosis isolates from East China in 2009, 2011, pp.11, 78~
37. Falzon D, "WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update", Eur Respir J, 38, pp.516~528 (2011)[DOI]
38. Niehaus AJ, "High prevalence of inhA promoter mutations among patients with drug-resistant tuberculosis in KwaZulu-Natal, South Africa", PLoS One, 10, pp.e0135003~ (2015)[DOI]
39. Rahman A, "Pyrazinamide susceptibility and pncA mutation profiles of Mycobacterium tuberculosis among multidrug-resistant tuberculosis patients in Bangladesh", Antimicrob Agents Chemother, 61, pp.e00511~7 (2017)
40. Sowajassatakul A, "Molecular characterization of amikacin, kanamycin and capreomycin resistance in M", XDR-TB strains isolated in Thailand, 2014, pp.14, 165~

관련 논문AI추천